Potassium Dihydrogen Phosphate (Phebra) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: monobasic potassium phosphate
Pack: Potassium Dihydrogen Phosphate (Phebra) 1.361 g (potassium 10 mmol)/10 mL injection, 10 x 10 mL vials
Brand name
(ARTG)
: PHEBRA POTASSIUM DIHYDROGEN PHOSPHATE 13.6% (1.36 g in 10 mL) potassium phosphate - monobasic 10 mmol/10 mL concentrated injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 1 JANUARY 1991: Treatment of severe hypophosphataemia (serum levels <0.3mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. Lowering the pH of urine. The treatment of potassium depletion in patients with hypokalaemia; IV administration is indicated when the patient is unable to take potassium orally or if hypokalemia is severe.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, intravenous infusion
- Intravenous
- a clear and colourless or faintly straw coloured, particle-free solution
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is
- 10mL x 10 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
